Work

Abstract CT515: A phase I/IB trial of binimetinib in combination with erlotinib in NSCLC harboring KRAS or EGFR mutation

Year: 2022

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2022-ct515

Authors: Andreas N. Saltos, Benjamin C. Creelan, Tawee Tanvetyanon, Alberto A. Chiappori, Scott J. Antonia, Michael R. Shafique, Milijana Ugrenovic-Petrovic, Samer Sansil, Anthony M. Neuger, Jongphil Kim, Eric Haura, Jhanelle Gray

Institutions: Moffitt Cancer Center, Duke Cancer Institute

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4282966656

Cites:

Cited by:

Related to: 10